NVO · Novo Nordisk A S

$46.26 -0.93 (-1.97%)

Market Cap

$208.50B

4.42B

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	Filing Date	Period
6-K	2026-08-24	—
6-K	2026-08-18	2026-08-17
6-K	2026-08-10	—
6-K	2026-08-10	2026-08-06
6-K	2026-08-04	2026-06-30
6-K	2026-08-04	—
6-K	2026-08-04	—
6-K	2026-07-31	—
6-K	2026-07-27	—
6-K	2026-07-21	2026-07-20
6-K	2026-07-13	—
6-K	2026-07-06	—
6-K	2026-06-29	—
6-K	2026-06-24	2026-06-22
6-K	2026-06-15	—
6-K	2026-06-08	—
6-K	2026-06-01	—
6-K	2026-05-27	2026-05-26
6-K	2026-05-22	—
6-K	2026-05-22	—
6-K	2026-05-18	—
6-K	2026-05-13	2026-05-12
6-K	2026-05-06	2026-03-31
6-K	2026-05-05	—
6-K	2026-04-27	—
6-K	2026-04-20	—
6-K	2026-04-20	—
6-K	2026-04-13	—
6-K	2026-04-07	—
6-K	2026-03-30	—
6-K	2026-03-27	—
6-K	2026-03-27	—
6-K	2026-03-26	—
6-K	2026-03-23	—
6-K	2026-03-20	2026-03-19
6-K	2026-03-17	2026-03-16
6-K	2026-03-09	—
6-K	2026-03-02	—
6-K	2026-03-02	—
6-K	2026-02-23	—
6-K	2026-02-23	—
6-K	2026-02-20	—
6-K	2026-02-17	2026-02-16
6-K	2026-02-11	—
6-K	2026-02-10	—
6-K	2026-02-09	—
6-K	2026-02-05	2026-02-04
6-K	2026-02-05	2026-02-04
6-K	2026-02-05	—
6-K	2026-02-04	2025-12-31

Showing 1–50 of 550 filings

Key facts CIK 353278 CUSIP 670100205 13F (30d) 947 filings 930 filers Visit website Investor relations